Previous close | 25.57 |
Open | 25.57 |
Bid | 25.75 |
Ask | 26.60 |
Strike | 330.00 |
Expiry date | 2023-04-21 |
Day's range | 25.57 - 25.57 |
Contract range | N/A |
Volume | |
Open interest | 135 |
We think all investors should try to buy and hold high quality multi-year winners. And highest quality companies can...
The FDA approves Eli Lilly's Jaypirca (pirtobrutinib) under an accelerated approval pathway as a treatment for mantle cell lymphoma (MCL).
AstraZeneca's (AZN) Evusheld is no longer authorized for use in the United States after laboratory data showed that it does not neutralize Omicron subvariants.